A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
Clinical trial NCT06127043 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06127043
- Sponsor
- AnaptysBio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-04
- Primary completion
- 2026-01-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.